1 |
Studies of the metabolic effects of acute insulin deficiency. I. Mechanism of impairment of hepatic fatty acid and protein synthesis.  |
미소장 |
2 |
Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis  |
미소장 |
3 |
Nelson RW. Canine diabetes mellitus. In: Feldman EC, Nelson RW, Reusch CE, Catharine J, Scott-Moncrieff R (eds.). Canine & Feline endocrinology. 4th ed. St. Louis (MO): Elsevier Saunders ; 2015. p. 213-257. |
미소장 |
4 |
The mechanism of glycosuric diuresis in diabetic man.  |
미소장 |
5 |
Factors contributing to the degree of polyuria in a patient with poorly controlled diabetes mellitus  |
미소장 |
6 |
Canine diabetes mellitus: can old dogs teach us new tricks?  |
미소장 |
7 |
Nelson RW. Disorders of the endocrine pancreas. In: Nelson RW, Couto CG (eds.). Small animal internal medicine. 5th ed. St. Louis (MO): Elsevier Saunders ; 2014. p. 777-823. |
미소장 |
8 |
Nelson RW. Canine diabetes mellitus. In: Ettinger SJ, Feldman EC (eds.). Textbook of veterinary internal medicine. 7th ed. St. Louis (MO): Elsevier Saunders ; 2010. p. 1782-1796. |
미소장 |
9 |
Rand JS, Fleeman LM, Farrow HA, Appleton DJ, Lederer R. Canine and feline diabetes mellitus: nature or nurture? J Nutr 2004 ; 134:2072S-2080S. |
미소장 |
10 |
The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin  |
미소장 |
11 |
Synthetic insulin analogs and their use in dogs and cats.  |
미소장 |
12 |
Mechanism of protracted metabolic effects of fatty acid acylated insulin, NN304, in dogs: retention of NN304 by albumin.  |
미소장 |
13 |
Behrend EN, Civco TD, Booth DM. Drug therapy for endocrinopathies. In: Booth DM (ed.). Small animal clinical pharmacology & therapeutics. 2nd ed. St. Louis (MO): Elsevier Saunders ; 2012. p. 783-847. |
미소장 |
14 |
Insulin detemir under steady‐state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes  |
미소장 |
15 |
Heise T, Pieber TR. Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies. Diabetes Obes Metab 2007 ; 9:648-659. |
미소장 |
16 |
Time-action profiles of insulin detemir in normal and diabetic dogs.  |
미소장 |
17 |
Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial.  |
미소장 |
18 |
Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes  |
미소장 |
19 |
Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.  |
미소장 |
20 |
Hermansen K, Madsbad S, Perrild H, Kristensen A, Axelsen M. Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy. Diabetes Care 2001 ; 24:296-301. |
미소장 |
21 |
Pieber TR, Draeger E, Kristensen A, Grill V. Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin. Diabet Med 2005 ; 22:850-857. |
미소장 |
22 |
Inpatient Management of Hyperglycemia and Diabetes  |
미소장 |